post-bg-474
calendary March 28, 2024

The world's first drug to combat severe frostbite has been approved

The US Food and Drug Administration (FDA) has approved the first drug to combat severe frostbite. The drug Aurlumyn (iloprost) showed its effectiveness in clinical trials involving 47 people.

Aurlumyn (iloprost) is a vasodilator drug where active ingredient is iloprost - the synthetic analogue of prostacyclin PGI2. Iloprost improves blood flow to tissues, inhibits platelet aggregation and reduces high blood pressure. In 2004, iloprost was approved for the treatment of pulmonary arterial hypertension (PAH). At that time, it was the first inhaled drug for the treatment of PAH in the United States. In 2017, the development of an injectable dosage form with iloprost began to combat frostbite.

As part of a clinical study of the use of iloprost to combat severe frostbite, patients were divided into three groups:

  1. Patients of the first group were administered iloprost intravenously for 6 hours for 8 days.
  2. Patients of the second group took other drugs not approved for use in frostbite + iloprost.
  3. Patients of the third group took other drugs.

All participants also received intravenous aspirin and standard care for frostbite.

On the seventh day of therapy, none of the 16 patients receiving iloprost alone required amputation. Nine of 15 subjects in the group receiving the unapproved drug + iloprost also eliminated the need for amputation.

Eicos, which owns the rights to Aurlumyn, is also exploring the use of iloprost as a treatment for circulatory disorders, extracorporeal membrane oxygenation and systemic scleroderma (a condition that can lead to amputation).

Three iloprost preparations are registered in Russia, which are inhalation solutions intended for the treatment of PAH. Two out of three registration certificates belong to Russian companies. One is German.

References:
  1. https://pharmvestnik.ru/content/news/FDA-odobrilo-pervyi-v-istorii-preparat-pri-tyajelyh-obmorojeniyah.html
  2. https://grls.rosminzdrav.ru/
  3. https://www.drugs.com/aurlumyn.html

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE